RESUMO
OBJECTIVES: To study the pretreatment characteristics that predispose a patient to rupture and to compare the outcome after dilatation with the outcome after surgical myotomy. DESIGN: A survey of all patients treated for achalasia at the Creighton University Medical Center, Omaha, Neb, during a 16-year period. Clinical examination and testing of consenting patients at 12 months and longer after treatment. SETTING: Tertiary referral center. PATIENTS: Of the 61 patients, 55 were treated with dilatation. Esophageal rupture developed in 8 patients (14.5%) with achalasia after pneumatic dilatation; these patients underwent surgery for the rupture. Dilatation failed in 8 other patients; these patients underwent a surgical myotomy. Six patients underwent a primary surgical myotomy. MAIN OUTCOME MEASURES: Duration of symptoms, weight loss, lower esophageal sphincter resting pressure and relaxation, amplitude and quality of distal esophageal contractions (assessed by manometry), 24-hour esophageal pH, and maximal esophageal diameter (assessed by barium swallow examination). RESULTS: Surgical myotomy at a mean (+/-SEM) of 44.9 +/- 18.6 months alleviated dysphagia in 13 (93%) of the 14 patients compared with only 12 (39%) of the 31 patients after dilatation at a mean (+/-SEM) of 55.0 +/- 11.7 months (P < .001). Of the 14 patients who underwent surgical myotomy, 13 (93%) were able to return to a normal diet compared with only 2 (7%) of the 31 patients who underwent dilatation (P < .001). Compared with patients without perforations, patients with perforations after pneumatic dilatation had pretreatment characteristics consistent with "early" disease: shorter symptom duration (20.1 +/- 5.4 vs 68.9 +/- 4.9 months, P < .001), less weight loss (4.7 +/- 1.2 vs 10.3 +/- 0.8 kg, P < .001), a less dilated esophagus (24.0 +/- 1.8 vs 45.6 +/- 3.0 mm, P < .005), lower lower esophageal sphincter resting pressures (19.3 +/- 2.6 vs 34.2 +/- 1.3 mm Hg, P < .001), a greater percentage of lower esophageal sphincter relaxation (47.6% +/- 4.9% vs 20.7% +/- 2.1%, P < .001), and a lower percentage of synchronous contractions in the distal esophageal body (66.2% +/- 4.9% vs 85.3% +/- 2.3%, P < .005). (All data given as the mean [+/-SEM].) All patients with pneumatic perforations were successfully treated by thoracotomy and surgical repair. CONCLUSIONS: Surgical myotomy provides a better long-term outcome. The early disease stage is associated with perforation after pneumatic dilatation. Surgical myotomy rather than balloon dilatation should be considered in patients with early achalasia.
Assuntos
Cateterismo , Acalasia Esofágica/terapia , Adulto , Idoso , Cateterismo/efeitos adversos , Acalasia Esofágica/fisiopatologia , Esôfago/imunologia , Feminino , Seguimentos , Humanos , Masculino , Manometria , Pessoa de Meia-Idade , Recidiva , Ruptura/etiologia , Procedimentos Cirúrgicos Operatórios/métodosRESUMO
The duodenal switch operation preserves the pylorus and the proximal 3 to 7 cm of duodenum in continuity with the stomach while diverting pancreaticobiliary secretions. We compared it with the Roux-en-Y without vagotomy or antrectomy in 12 dogs with innervated gastric pouches. Acid secretion was inhibited between tests using ranitidine in the Roux-en-Y group only, but two of the six dogs still developed stomal ulcers and the remainder showed stomal hyperemia. This may be due to a significant increase in gastric acid output after Roux-en-Y, but gastric emptying and plasma gastrin, cholecystokinin, secretin, gastric inhibitory polypeptide, peptide YY, and neurotensin were similar after both procedures. In 12 patients and a further 6 dogs, the duodenal switch caused no significant change in the intragastric pH environment as assessed by intragastric pH monitoring. The duodenal switch is a suitable procedure for pancreaticobiliary diversion.
Assuntos
Refluxo Duodenogástrico/cirurgia , Duodeno/cirurgia , Jejunostomia , Anastomose em-Y de Roux , Animais , Cães , Feminino , Ácido Gástrico/metabolismo , Determinação da Acidez Gástrica , Esvaziamento Gástrico/fisiologia , Hormônios Gastrointestinais/metabolismo , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-IdadeRESUMO
AIMS: Overactive bladder (OAB) is common in men and may exist concomitantly with benign prostatic hyperplasia (BPH) and obstruction. We present a subanalysis of results from men with OAB in a 6-month, open-label study of treatment with the oxybutynin transdermal system (OXY-TDS). Broad entry criteria were incorporated to yield a clinically representative population. METHODS: All participants received OXY-TDS 3.9 mg/day. Effectiveness was assessed by changes in scores on validated questionnaires, which included the single-item Patient Perception of Bladder Condition (PPBC), the King's Health Questionnaire (KHQ) and the Beck Depression Inventory-II (BDI-II). RESULTS: The proportion of men (n=369; mean age=69.6 years) who reported that their bladder condition caused moderate, severe or many severe problems (PPBC>or=4) improved from 77.3% at baseline to 38.1-53.6% in subsequent months. Mean KHQ scores decreased significantly (p
Assuntos
Ácidos Mandélicos/administração & dosagem , Antagonistas Muscarínicos/administração & dosagem , Hiperplasia Prostática/complicações , Bexiga Urinária Hiperativa/tratamento farmacológico , Bexiga Urinária Hiperativa/etiologia , Administração Cutânea , Adulto , Idoso , Indicadores Básicos de Saúde , Humanos , Masculino , Ácidos Mandélicos/uso terapêutico , Pessoa de Meia-Idade , Antagonistas Muscarínicos/uso terapêutico , Estudos Prospectivos , Qualidade de Vida , Resultado do TratamentoRESUMO
There is some controversy regarding the association of upper esophageal symptoms and acid gastroesophageal reflux. We carried out gastric acid analysis, 24-h esophageal pH measurement, and esophageal manometry in 150 patients with symptoms suggestive of gastroesophageal reflux disease. Of these, 22 (15%) had gastric acid hypersecretion [basal acid output level > 5 mmol/h (19 patients) or maximum acid output level > 30 mmol/h (13 patients)]. They were compared to 25 consecutive patients with normal gastric acid secretion. An incompetent lower esophageal sphincter was identified in a similar number of hypersecretors (HS) (59.1%) and normosecretors (NS) (44%). Esophageal acid exposure was more common in HS than in NS (score, 70 vs. 36.1, p < 0.05). This was reflected as a higher incidence of esophagitis in HS (67 vs. 14%, p < 0.0025). Symptoms of cervical dysphagia were present in eight of 22 HS and one of 25 NS (p = 0.009). There was no anatomical lesion on endoscopy to explain the dysphagia. Upper esophageal sphincter (UES) manometry showed normal pharyngeal pressure, resting UES pressure, and length in both groups. The mean closing UES pressure was 127 mm Hg in HS and 114 mm Hg in NS (0.1 > p > 0.05). The HS with cervical dysphagia were no different from HS without dysphagia in any respect. We conclude that patients with gastric acid hypersecretion have more acid reflux, esophagitis, and cervical dysphagia. This is not associated with demonstrable abnormality in stationary manometry. Prolonged measurement may be required to show any change.